科言猫
学术研究的AI总结
首页
文献互助
订阅
我的收藏
科研工具
选题分析
论文总结
专利管理
未登录
返回
M
Ming‐Cheng Chang
national atomic research institute
34
H指数
120
论文数
3.3K
被引数
0
相关解读
订阅
收录论文
31
发表时间
发表时间
IF
被引数
CCKBR (Gastrin Receptor) as a Theranostic Target in Oncology: Biological Rationale, Diagnostic Imaging, and Next-Generation Peptide-Based Drug Development
CCKBR(胃泌素受体)作为肿瘤学中的诊疗靶点:生物学依据、诊断成像及下一代基于肽类药物的开发
Pharmaceutics
IF
5.5
2026-09-23
0
OA
AI
Ming-Cheng Chang; Chun-Tang Chen; Wan-Chi Lee; Yi-Jou Tai; Ying-Cheng Chiang
分享
收藏
BTLA: An Emerging Immune Checkpoint Target in Cancer Immunotherapy
BTLA:癌症免疫治疗中新兴的免疫检查点靶点
Pharmaceuticals 2025, Vol. 18, Page 1784
IF
4.8
2025-11-24
0
OA
AI
Ming-Cheng Chang; Wan-Chi Lee; Yi-Jou Tai; Ying-Cheng Chiang
分享
收藏
Iodine-123 Metaiodobenzylguanidine (I-123 MIBG) in Clinical Applications: A Comprehensive Review
碘123间碘苄基胍 (I-123 MIBG) 在临床应用中的综合评价
PHARMACEUTICALS
IF
4.8
2024-11-21
0
OA
AI
Chang, Ming-Cheng; Peng, Cheng-Liang; Chen, Chun-Tang; Shih, Ying-Hsia; Chen, Jyun-Hong; Tai, Yi-Jou; Chiang, Ying-Cheng
分享
收藏
The Role of Chitinase-3-like Protein-1 (YKL40) in the Therapy of Cancer and Other Chronic-Inflammation-Related Diseases
PHARMACEUTICALS
IF
4.8
2024-02-27
10
OA
AI
Chang, Ming-Cheng; Chen, Chun-Tang; Chiang, Ping-Fang; Chiang, Ying-Cheng
分享
收藏
Develop companion radiopharmaceutical YKL40 antibodies as potential theranostic agents for epithelial ovarian cancer
BIOMEDICINE & PHARMACOTHERAPY
IF
7.5
2022-11-01
4
OA
AI
Chang, Ming-Cheng; Chiang, Ping-Fang; Kuo, Yu-Jen; Peng, Cheng-Liang; Chen, I. -Chun; Huang, Chia-Yen; Chen, Chi-An; Chiang, Ying-Cheng
分享
收藏
Liposomal dexamethasone-moxifloxacin nanoparticle combinations with collagen/gelatin/alginate hydrogel for corneal infection treatment and wound healing
BIOMEDICAL MATERIALS
IF
3.7
2020-07-27
43
OA
AI
Chang, Ming-Cheng; Kuo, Yu-Jen; Hung, Kuo-Hsuan; Peng, Cheng-Liang; Chen, Kuan-Yin; Yeh, Lung-Kun
分享
收藏
CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer
EPIGENOMICS
IF
2.6
2018-10-16
13
OA
AI
Lin, Han-Wei; Fu, Chi-Feng; Chang, Ming-Cheng; Lu, Tzu-Pin; Lin, Hsiu-Ping; Chiang, Ying-Cheng; Chen, Chi-An; Cheng, Wen-Fang
分享
收藏
Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation
CANCER LETTERS
IF
10.1
2018-07-01
39
PRE
AI
Chen, Yu-Li; Chang, Ming-Cheng; Chiang, Ying-Cheng; Lin, Han-Wei; Sun, Nai-Yun; Chen, Chi-An; Sun, Wei-Zen; Cheng, Wen-Fang
分享
收藏
Irradiation Enhances Abscopal Anti-tumor Effects of Antigen-Specific Immunotherapy through Regulating Tumor Microenvironment
MOLECULAR THERAPY
IF
12
2018-02-01
37
OA
AI
Chang, Ming-Cheng; Chen, Yu-Li; Lin, Han-Wei; Chiang, Ying-Cheng; Chang, Chi-Fang; Hsieh, Shu-Feng; Chen, Chi-An; Sun, Wei-Zen; Cheng, Wen-Fang
分享
收藏
Local irradiation promotes antitumor immunity and abscopal effect of antigen-specific immunotherapy by enhancing dendritic cell maturation
CANCER RESEARCH
IF
16.6
2017-07-01
2
PRE
AI
Chang, Ming-Cheng; Cheng, Jason Chia-Hsien; Chiang, Ying-Cheng
分享
收藏
Urokinase-type Plasminogen Activator Resulting from Endometrial Carcinogenesis Enhances Tumor Invasion and Correlates with Poor Outcome of Endometrial Carcinoma Patients
SCIENTIFIC REPORTS
IF
3.9
2015-06-02
12
OA
AI
Huang, Chia-Yen; Chang, Ming-Cheng; Huang, Wei-Yun; Huang, Ching-Ting; Tang, Yu-Chien; Huang, Hsien-Da; Kuo, Kuan-Ting; Chen, Chi-An; Cheng, Wen-Fang
分享
收藏
Insulin-like growth factors inhibit dendritic cell-mediated anti-tumor immunity through regulating ERK1/2 phosphorylation and p38 dephosphorylation
CANCER LETTERS
IF
10.1
2015-04-01
43
PRE
AI
Huang, Ching-Ting; Chang, Ming-Cheng; Chen, Yu-Li; Chen, Tsung-Ching; Chen, Chi-An; Cheng, Wen-Fang
分享
收藏
CD40 combined toll-like receptor 3 ligation restore morphine-induced reducing dendritic cells-mediating immunity and antitumor effect.
CANCER RESEARCH
IF
16.6
2014-04-02
0
PRE
AI
Chang, Ming-Cheng; Chen, Yu-Li; Sun, Wei-Zen; Cheng, Wen-Fang
分享
收藏
The influences of morphine on dendritic cell-mediated immunity
CANCER RESEARCH
IF
16.6
2012-04-01
0
PRE
AI
Chang, Ming-Cheng; Chen, Yu-Li; Huang, Ching-Ting; Chiang, Ying-Cheng; Huang, Chia-Yen; Cheng, Wen-Fang; Chen, Tzer-Ming
分享
收藏
Depletion of regulatory T lymphocytes reverses the imbalance between Pro- and anti-tumor immunities via enhancing antigen-specific T cell immune responses
CANCER RESEARCH
IF
16.6
2012-04-01
0
PRE
AI
Chen, Yu-Li; Chang, Ming-Cheng; Huang, Chia-Yen; Chang, Ying-Cheng; Chen, Yun-Yuan; Wang, Ju-Ming; Cheng, Wen-Fang
分享
收藏
Serous ovarian carcinoma patients with high alpha-folate receptor had poorer outcome by reducing cytotoxic chemo-response through anti-apoptotic pathway
CANCER RESEARCH
IF
16.6
2012-04-01
0
PRE
AI
Huang, Ching-Ting; Chen, Yu-Li; Chang, Ming-Cheng; Huang, Chia-Yen; Chiang, Ying-Cheng; Cheng, Wen-Fang
分享
收藏
Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways
间皮素通过MAPK/ERK和JNK途径诱导MMP-7增强卵巢癌的侵袭
BIOCHEMICAL JOURNAL
IF
4.3
2012-02-13
136
PRE
AI
Chang, Ming-Cheng; Chen, Chi-An; Chen, Pao-Jen; Chiang, Ying-Cheng; Chen, Yu-Li; Mao, Tsui-Lien; Lin, Han-Wei; Chiang, Wen-Hsien Lin; Cheng, Wen-Fang
分享
收藏
Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response
MOLECULAR ONCOLOGY
IF
4.5
2011-12-20
122
OA
AI
Chen, Yu-Li; Chang, Ming-Cheng; Huang, Chia-Yen; Chiang, Ying-Cheng; Lin, Han-Wei; Chen, Chi-An; Hsieh, Chang-Yao; Cheng, Wen-Fang
分享
收藏
Regional economic impact analysis of earthquakes in northern Taiwan and its implications for disaster reduction policies
NATURAL HAZARDS
IF
3.7
2011-11-26
11
PRE
AI
Lin, H. C.; Kuo, Y. L.; Shaw, D.; Chang, M. C.; Kao, T. M.
分享
收藏
Mesothelin enhances ovarian cancer invasion of by inducing MMP-7 through MAPK/ERK and JNK pathways
CANCER RESEARCH
IF
16.6
2011-04-01
1
PRE
AI
Chang, Ming-Cheng; Chen, Chi-An; Chiang, Ying-Cheng; Chen, Tzer-Ming; Cheng, Wen-Fang
分享
收藏
研究方向
暂时未获取到该数据
合作学者
合作期刊
M
Min‐Liang Kuo
H 指数: 73 · 论文数: 339
W
Wen‐Fang Cheng
H 指数: 55 · 论文数: 392
W
Wu‐Shiun Hsieh
H 指数: 54 · 论文数: 340
R
Ruey‐Hwa Chen
H 指数: 53 · 论文数: 181
C
Chi‐An Chen
H 指数: 45 · 论文数: 284
查看更多